Skip to search formSkip to main contentSkip to account menu

90Y-DOTA-biotin

Known as: Yttrium Y 90-DOTA-Biotin, yttrium Y 90 DOTA-biotin 
A radioconjugate of biotin and yttrium Y 90 (Y-90) linked through the bifunctional macrocyclic chelating agent tetra-azacyclododecanetetra-acetic… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Biotin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Intraoperative Avidination for Radionuclide Therapy: A Prospective New Development to Accelerate Radiotherapy in Breast Cancer
Purpose: In a continuous effort to seek for anticancer treatments with minimal side effects, we aim at proving the feasibility of… 
2007
2007
IntraoperativeAvidination for RadionuclideTherapy : AProspective New Development toAccelerate Radiotherapy in Breast Cancer
Purpose: In a continuous effort to seek for anticancer treatments with minimal side effects, we aim at proving the feasibility of… 
2006
2006
Efficacy and toxicity of 90Y-DOTA-biotin after pretargeted intratumoral avidin in mice implanted with human breast cancer (HBT 3477)
2003
2003
Comparison of anti-CD 20 and anti-CD 45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas
Radiolabeled anti-CD20 antibodies produce responses in 60% to 95% of patients with relapsed non-Hodgkin lymphoma (NHL); however… 
2003
2003
Innate immunity and cancer : Genetics , specificity and function of natural monoclonal IgM antibodies
Innate immune mechanisms are crucial for first defense and initiation of secondary responses to “nonself” structures. This has… 
2000
2000
Pre-targeted radioimmunotherapy of human colon cancer xenografts in athymic mice using streptavidin-CC49 monoclonal antibody and 90Y-DOTA-biotin.
Radioimmunotherapy of solid malignancies using directly labelled 90Y-monoclonal antibodies has been associated in clinical trials… 
2000
2000
Pre-targeted radioimmunotherapy of human colon cancer xenografts in athymic mice using streptavidin-CC49 monoclonal antibody and 90Y-DOTA-biotin
Radioimmunotherapy of solid malignancies using directly labelled 90Y-monoclonal antibodies has been associated in clinical trials… 
2000
2000
Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody / Streptavidin in Patients with Metastatic Colon Cancer 1
A Phase II study of yttrium-90-tetra-azacyclododecanetetra-acetic acid-biotin ( Y-DOTA-biotin) pretargeted by NR-LU-10 antibody… 
1997
1997
Biodistribution in tumour‐bearing mice of two 90Y‐labelled biotins using three‐step tumour targeting
Tumour pretargeting techniques based on a three-step approach with the avidin/biotin system and associated with the high-energy… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)